Michael Dilling, PhD, MBA

Michael Dilling, Ph.D., Certified Licensing Professional (CLP)

Michael Dilling is Executive Director of Commercialization at the BCM Innovation Institute, the integrated commercialization team at Baylor College of Medicine (BCM) - a nationally recognized biomedical research institution and the only private medical school in the Southwestern U.S. 

BCM leads all Texas-based institutions in NIH research funding and hosts top-ranked departments. Under Dilling’s leadership, BCMII builds strategic commercial partnerships that help translate biomedical discoveries into products and services that benefit patients and support BCM’s academic mission. Over the past five fiscal years, the team has completed 250+ licensing transactions and negotiated industry-sponsored research and services contracts valued at over $95 million.

Dilling oversees the BCMII team of six technology management professionals, a compliance expert, and a team of three financial professionals. With over 25 years of experience in academic technology commercialization, he has negotiated or guided the negotiation of hundreds of agreements between BCM and commercial partners. He also teaches the graduate course “Commercialization of Biomedical Technologies”, covering IP, startup formation, fundraising, and product development.

An active member of the Association of University Technology Managers (AUTM), Dilling contributes to its Mentorship Committee and helped develop new mentorship tools. He holds a Ph.D. in Genetics from Texas A&M (1993), an MBA from the University of Memphis (1999), and completed postdoctoral work at St. Jude Children’s Research Hospital. He joined BCM in 2000.